- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 24 results
Speaking Engagement
November 3, 2022
Dirk Lasater to Speak at Accelerate Investor Conference 2022
Speaking Engagement
October 27, 2022
Daniel R. Kahan to speak at Thomson Reuters 18th Annual Southeastern M&A/Private Equity Forum
Conference
October 20, 2022
Federal M&A Outlook 2023: Transformative Transactions in a Complex Antitrust Environment
Speaking Engagement
September 28, 2022
Tamra Moore, Adam Solander to Speak on Harvard Business School Association of Northern California’s Webinar About AI in Healthcare and Life Sciences
Speaking Engagement
September 19, 2022
Dan Kahan to Speak at Association of Corporate Counsel’s National Capital Region Event
Speaking Engagement
May 23, 2022
Daniel R. Kahan to Speak at Berkeley Center for Law & Technology Event About FinTech Law
Speaking Engagement
October 28, 2021
Tom Knox, Dan Kahan to Speak on Association of Corporate Counsel – National Capital Region Webinar
Speaking Engagement
July 29, 2021
Tom Knox, Laura Bushnell, Dan Kahan to Speak at NVCA Webinar on Corporate Venture Capital
Speaking Engagement
June 15, 2021
Chris Markus to Speak About Gene & Cell Therapy Manufacturing at Global Regulatory Affairs Conference
Speaking Engagement
May 25, 2021
Chris Markus to Speak at 10th Annual Global Pharma Regulatory Summit
Speaking Engagement
March 9, 2021
Chris Markus to Speak at Food and Drug Law Institute’s Introduction to Biologics and Biosimilars Law and Regulation Event
Speaking Engagement
March 8, 2021
Chris Markus to Speak at FDA/Xavier PharmaLink 2021 Conference